Lower vitamin D levels were associated with poorer overall survival, melanoma-specific survival, and disease-free survival independent of a strong association between lower vitamin D and higher C-reactive protein, a study published in the Journal of Clinical Oncology has shown.1
Scientific Publications
VIDEO: Speaker provides updates on BRAF/MEK combination therapies
NEW YORK — Jason J. Luke, MD, FACP, assistant professor of Medicine at The University of Chicago Medicine, discussed the current status of the use of combination BRAF/MEK therapy in patients with BRAF-mutated melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.
Brain may become ‘just another organ’ in treatment of metastatic melanoma
NEW YORK — A new paradigm is evolving for the treatment of brain metastases from melanoma that involves a greater role of systemic therapy, according to a speaker at HemOnc Today Melanoma and Cutaneous Malignancies.
Intralesional therapy ‘here to stay’ for melanoma
NEW YORK — There are many ongoing monotherapy and combination trials of oncolytic agents, according to a speaker at HemOnc Today Melanoma and Cutaneous Malignancies.